Kaplan Fox Reminds Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Seek a Leadership Role Before Deadline on November 3, 2026Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
BBNX Shareholder Alert: November 3, 2026 Lead Plaintiff Deadline in Beta Bionics, Inc. Securities Class Action - Contact Levi & KorsinskyWall Street stayed constructive on BBNX even after the FDA Warning Letter surfaced, with Leerink writing on January 30, 2026 that management "highlighted there have been no new issues" and Truist stating on February 17, 2026 that the letter was "not on the safety or performance of the company's insulin pump itself." A securities class action alleges those analyst views rested on Company statements that minimized more than 18,000 unreported iLet complaints
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action LawsuitLOS ANGELES, Oct. 12, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP, a national shareholder rights litigation firm, announces that it has filed a federal securities class action on behalf of purchasers of Beta Bionics, Inc. (“Beta Bionics” or “the Company”) (
NASDAQ: BBNX) common stock between July 30, 2025 and February 24, 2026, inclusive (the “Class Period”). Beta Bionics investors have until November 3, 2026 to seek appointment as lead plaintiff of the purported class in the Beta Bionics class action lawsuit. The complaint in Holtzman v. Beta Bionics, Inc. et al., No. 2:26-cv-09999 (C.D Cal.) charges Beta Bionics and certain of the Company’s top executive officers with violations of the Securities Exchange Act of 1934.
Kaplan Fox Notifies Investors of Beta Bionics, Inc. (NASDAQ: BBNX) of a Securities Fraud Class Action Deadline on November 3, 2026NEW YORK, Oct. 12, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (
NASDAQ: BBNX) on behalf of investors that purchased or otherwise acquired Beta Bionics common stock between July 30, 2025 and February 24, 2026 (the “Class Period”).
Kaplan Fox Notifies Investors of Beta Bionics, Inc. (NASDAQ: BBNX) of the Lead Plaintiff Deadline on November 3, 2026Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
BBNX Investor Alert: Beta Bionics, Inc. Securities Class Action Notice - Contact Levi & KorsinskyNEW YORK CITY, NY / ACCESS Newswire / October 9, 2026 / Levi & Korsinsky, LLP reminds purchasers of Beta Bionics, Inc. (
NASDAQ:BBNX) securities that a class action is pending on behalf of shareholders who acquired shares between July 30, 2025 and February 24, 2026. See if you could be eligible to recover. You may also contact Joseph E. Levi, Esq. at jlevi@levikorsinsky.com or (212) 363-7500.
Kaplan Fox Encourages Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Contact the Firm Before the Lead Plaintiff Deadline on November 3, 2026NEW YORK, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (
NASDAQ: BBNX) on behalf of investors that purchased or otherwise acquired Beta Bionics common stock between July 30, 2025 and February 24, 2026 (the “Class Period”).
Kaplan Fox Urges Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Contact the Firm Before the Deadline on November 3, 2026Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Beta Bionics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Beta Bionics, Inc. - BBNXNEW ORLEANS, Oct. 08, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 3, 2026 to file lead plaintiff applications in a securities class action lawsuit against Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NasdaqGM: BBNX), if they purchased or otherwise acquired the Company’s common stock between July 30, 2025 and February 24, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Central District of California.
BBNX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Beta Bionics, Inc. and Encourages Investors to Contact the FirmBragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Beta Bionics (BBNX) To Contact Him Directly To Discuss Their Options
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action LawsuitLOS ANGELES, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP, a national shareholder rights litigation firm, announces that it has filed a federal securities class action on behalf of purchasers of Beta Bionics, Inc. (“Beta Bionics” or “the Company”) (
NASDAQ: BBNX) common stock between July 30, 2025 and February 24, 2026, inclusive (the “Class Period”). Beta Bionics investors have until November 3, 2026 to seek appointment as lead plaintiff of the purported class in the Beta Bionics class action lawsuit. The complaint in Holtzman v. Beta Bionics, Inc. et al., No. 2:26-cv-09999 (C.D Cal.) charges Beta Bionics and certain of the Company’s top executive officers with violations of the Securities Exchange Act of 1934.
Kirby McInerney LLP Alerts Investors Who Acquired Beta Bionics, Inc. BBNX Securities Between July 30, 2025 and February 24, 2026 of Pending LawsuitKirby McInerney LLP reminds Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (
NASDAQ: BBNX) investors of the November 3, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action. Investors are encouraged to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
Kaplan Fox Reminds Investors of a Securities Class Action Against Beta Bionics, Inc. (NASDAQ: BBNX) - Deadline is November 3, 2026Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
BBNX SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Beta Bionics (NASDAQ: BBNX) Investors of Securities Class Action Lawsuit Deadline on November 3, 2026Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Beta Bionics To Contact Him Directly To Discuss Their Options
Kaplan Fox Reminds Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to a Securities Class Action Deadline – Contact the Firm Before November 3, 2026NEW YORK, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (
NASDAQ: BBNX) on behalf of investors that purchased or otherwise acquired Beta Bionics common stock between July 30, 2025 and February 24, 2026 (the “Class Period”).
Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application DeadlineNEW YORK and NEW ORLEANS, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (NasdaqGM: BBNX) of a class action securities lawsuit.
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Beta Bionics, Inc. of Class Action Lawsuit and Upcoming Deadlines – BBNXNEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (
NASDAQ: BBNX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Kaplan Fox Advises Beta Bionics, Inc. (NASDAQ: BBNX) Investors to Act Before the Lead Plaintiff Deadline on November 3, 2026Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Beta Bionics, Inc. (BBNX)NEW YORK, Oct. 06, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Beta Bionics, Inc. (“Beta Bionics” or the “Company”) (
NASDAQ: BBNX) between June 30, 2025 and February 24, 2026, inclusive.
Kaplan Fox Announces a Securities Class Action Filed Against Beta Bionics, Inc. (NASDAQ: BBNX) - Lead Plaintiff Deadline is November 3, 2026Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
NASDAQ: BBNX INVESTOR ALERT: Berger Montague Advises Beta Bionics, Inc. (NASDAQ: BBNX) Investors of a November 3, 2026 DeadlinePHILADELPHIA, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Berger Montague PC, a leading national plaintiffs' law firm, announces a class action lawsuit against Beta Bionics, Inc. (
NASDAQ: BBNX) ("Beta Bionics" or the "Company") on behalf of investors who purchased or acquired Beta Bionics securities during the period from July 30, 2025 through February 24, 2026 (the "Class Period"). The deadline to apply for lead plaintiff is November 3, 2026.
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action LawsuitLOS ANGELES, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP, a national shareholder rights litigation firm, announces that it has filed a federal securities class action on behalf of purchasers of Beta Bionics, Inc. (“Beta Bionics” or “the Company”) (
NASDAQ: BBNX) common stock between July 30, 2025 and February 24, 2026, inclusive (the “Class Period”). Beta Bionics investors have until November 3, 2026 to seek appointment as lead plaintiff of the purported class in the Beta Bionics class action lawsuit. The complaint in Holtzman v. Beta Bionics, Inc. et al., No. 2:26-cv-09999 (C.D Cal.) charges Beta Bionics and certain of the Company’s top executive officers with violations of the Securities Exchange Act of 1934.
